ARL11 Antibody

Code CSB-PA054255
Size US$166
Order now
Image
  • The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using CSB-PA054255(ARL11 Antibody) at dilution 1/50, on the right is treated with fusion protein. (Original magnification: ×200)
  • The image on the left is immunohistochemistry of paraffin-embedded Human lung cancer tissue using CSB-PA054255(ARL11 Antibody) at dilution 1/50, on the right is treated with fusion protein. (Original magnification: ×200)
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
ARL11
Alternative Names
ADP ribosylation factor like 11 antibody; ADP ribosylation factor like protein 11 antibody; ADP ribosylation factor like tumor suppressor protein 1 antibody; ADP-ribosylation factor-like protein 11 antibody; ADP-ribosylation factor-like tumor suppressor protein 1 antibody; ARL11 antibody; ARL11_HUMAN antibody; ARLTS1 antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Fusion protein of Human ARL11
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Isotype
IgG
Purification Method
Antigen affinity purification
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
Form
Liquid
Tested Applications
ELISA,IHC
Recommended Dilution
Application Recommended Dilution
ELISA 1:1000-1:5000
IHC 1:50-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
May play a role in apoptosis. May act as a tumor suppressor.
Gene References into Functions
  1. ARLTS1 gene mutations can be considered as a potential predisposing factor in familial hematological malignancies PMID: 27866680
  2. A statistically significant (p = 0.0037) decrease of ARLTS1 expression in prostate cancer cases was detected. PMID: 23940804
  3. the important role of ARLTS1 Cys148Arg variant as a contributor in prostate cancer predisposition PMID: 22028916
  4. A significantly increased risk was observed for young ovarian cancer patients with ARLTS1 Cys148Arg variant. PMID: 20067102
  5. The role of the allelic variants in ARLTS1, RAD51 and MDM2 acting in the tumor suppressor, DNA repair and p53 pathways as risk factors for familial breast cancer in 147 patients displaying characteristics of familial disease, was investigated. PMID: 20358297
  6. A novel tumor suppressor gene [ARLTS1 (ADP-ribosylation factor-like tumor suppressor gene 1)]is found to be altered in human carcinogenesis. It is located in Chromosome 13q14.3. PMID: 18375053
  7. A genetic variant of ARLTS1 predisposes patients to familial cancer. PMID: 15843669
  8. the G446A in ARLTS1 gene is probably not associated with an increased risk of sporadic breast cancer, prostate cancer, melanoma, thyroid papillary cancer or laryngeal cancer PMID: 16570116
  9. The study does not support the postulate that variants of ARLTS1 influence the risk of chronic lymphocytic leukemia(CLL). PMID: 16581122
  10. While ARLTS1 Trp149Stop did not influence melanoma risk (OR = 0.83, 95% CI = 0.37-1.88, p = 0.65), Cys148Arg revealed a statistically significant association with an increased risk for heterozygous carriers (OR = 1.43, 95% CI = 1.05-1.95, p = 0.02) PMID: 16646072
  11. we found no association of ARLTS1 polymorphisms and risk for familial chronic lymphocytic leukaemia PMID: 17391501
  12. Cysteine148Arginine variant is associated with a moderately increased risk of colorectal cancer, both in sporadic and familial cases. PMID: 17449901
  13. 650 transcripts expressed after restoration of ARLTS1 expression were identified in A549 cells, suggesting that pathways involved in cell survival, proliferation, signaling, and development mediate the effects of wild-type ARLTS1 in lung cancer. PMID: 17699778
  14. ARLTS1 germline variants are not associated with breast, prostate, and colorectal cancer PMID: 18337727
  15. Data show a significantly increased risk of familial OC for ARLTS1 Cys148Arg variant, which indicate that ARLTS1 may play a role in familial ovarian cancer. PMID: 19509554

Show More

Hide All

Involvement in disease
Leukemia, chronic lymphocytic (CLL)
Protein Families
Small GTPase superfamily, Arf family
Tissue Specificity
Expressed in lung and leukocytes.
Database Links

HGNC: 24046

OMIM: 151400

KEGG: hsa:115761

STRING: 9606.ENSP00000282026

UniGene: Hs.558599

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*